| 22/09/21 | 16:36:37 | 22 Sept 2021 | | Price Monitoring Extension | RNS |
| 24/08/21 | 11:07:12 | 24 Aug 2021 | | Director/PDMR Shareholding | RNS |
| 20/08/21 | 16:40:54 | 20 Aug 2021 | | Second Price Monitoring Extn | RNS |
| 20/08/21 | 16:35:36 | 20 Aug 2021 | | Price Monitoring Extension | RNS |
| 19/08/21 | 16:35:34 | 19 Aug 2021 | | Price Monitoring Extension | RNS |
| 17/08/21 | 08:50:56 | 17 Aug 2021 | | Notification of Major Holdings | RNS |
| 12/08/21 | 07:00:07 | 12 Aug 2021 | | FDA approves the Lupzuor™ PK study | RNS |
| 10/08/21 | 16:40:49 | 10 Aug 2021 | | Second Price Monitoring Extn | RNS |
| 10/08/21 | 16:35:27 | 10 Aug 2021 | | Price Monitoring Extension | RNS |
| 30/07/21 | 07:00:07 | 30 Jul 2021 | | Board Changes | RNS |
| 16/07/21 | 07:00:03 | 16 Jul 2021 | | Board Appointment | RNS |
| 28/06/21 | 12:27:22 | 28 Jun 2021 | | 2021 RESULT OF ANNUAL GENERAL MEETING -REPLACEMENT | RNS |
| 28/06/21 | 11:03:53 | 28 Jun 2021 | | 2021 RESULT OF ANNUAL GENERAL MEETING | RNS |
| 24/06/21 | 16:41:56 | 24 Jun 2021 | | Second Price Monitoring Extn | RNS |
| 24/06/21 | 16:36:51 | 24 Jun 2021 | | Price Monitoring Extension | RNS |
| 24/06/21 | 07:00:03 | 24 Jun 2021 | | Update: Lupzuor™ PK study | RNS |
| 02/06/21 | 07:00:03 | 2 Jun 2021 | | Notice of AGM and posting of Report & Accounts | RNS |
| 24/05/21 | 07:00:07 | 24 May 2021 | | Director Retirement | RNS |
| 29/04/21 | 16:35:29 | 29 Apr 2021 | | Price Monitoring Extension | RNS |
| 29/04/21 | 07:00:08 | 29 Apr 2021 | | Final Results | RNS |
| 16/04/21 | 16:41:17 | 16 Apr 2021 | | Second Price Monitoring Extn | RNS |
| 16/04/21 | 16:36:13 | 16 Apr 2021 | | Price Monitoring Extension | RNS |
| 25/02/21 | 16:41:05 | 25 Feb 2021 | | Second Price Monitoring Extn | RNS |
| 25/02/21 | 16:35:53 | 25 Feb 2021 | | Price Monitoring Extension | RNS |
| 09/02/21 | 07:00:05 | 9 Feb 2021 | | Update- scheduled Phase 3 trials in lupus patients | RNS |
| 18/01/21 | 07:00:07 | 18 Jan 2021 | | Appointment of Company Secretary | RNS |
| 04/01/21 | 07:00:11 | 4 Jan 2021 | | Holding(s) in Company | RNS |
| 02/12/20 | 07:00:07 | 2 Dec 2020 | | IMM TO PRESENT AT BIOTECH SHOWCASE DIGITAL 2021 | RNS |
| 30/11/20 | 07:00:06 | 30 Nov 2020 | | Total Share Capital Notification | RNS |
| 26/11/20 | 07:00:07 | 26 Nov 2020 | | Grant of Share Options & PDMR dealing | RNS |
| 24/11/20 | 07:00:02 | 24 Nov 2020 | | Conversion of Convertible Security | RNS |
| 23/11/20 | 07:00:06 | 23 Nov 2020 | | Conversion of Convertible Security | RNS |
| 20/11/20 | 07:00:03 | 20 Nov 2020 | | Update : FDA confirms 4 Dec for Type ‘A’ meeting | RNS |
| 18/11/20 | 07:00:07 | 18 Nov 2020 | | Total Share Capital Notification - Replacement | RNS |
| 10/11/20 | 07:00:07 | 10 Nov 2020 | | Update on submission to the FDA | RNS |
| 30/09/20 | 07:01:01 | 30 Sept 2020 | | Total Share Capital Notification | RNS |
| 30/09/20 | 07:00:04 | 30 Sept 2020 | | Interim Results | RNS |
| 29/09/20 | 07:00:03 | 29 Sept 2020 | | Share Subscription into Incanthera plc | RNS |
| 22/09/20 | 07:00:10 | 22 Sept 2020 | | Repayment of Convertible Security | RNS |
| 11/09/20 | 07:59:19 | 11 Sept 2020 | | Update on submission to the FDA | RNS |
| 10/09/20 | 10:59:29 | 10 Sept 2020 | | Conversion of Convertible Security | RNS |
| 09/09/20 | 13:45:35 | 9 Sept 2020 | | Conversion of Convertible Security | RNS |
| 08/09/20 | 15:49:04 | 8 Sept 2020 | | Holding(s) in Company | RNS |
| 08/09/20 | 09:00:06 | 8 Sept 2020 | | Director/PDMR Shareholding / TR -1 | RNS |
| 07/09/20 | 07:02:37 | 7 Sept 2020 | | Placing - update; related party transaction) | RNS |
| 03/09/20 | 07:00:07 | 3 Sept 2020 | | Conversion of Convertible Security | RNS |
| 02/09/20 | 07:00:03 | 2 Sept 2020 | | Placing to raise £6.5 million | RNS |
| 01/09/20 | 07:00:11 | 1 Sept 2020 | | Holding(s) in Company | RNS |
| 27/07/20 | 07:00:06 | 27 Jul 2020 | | FDA submission for Special Protocol Assessment | RNS |
| 18/06/20 | 11:31:36 | 18 Jun 2020 | | 2020 AGM – ALL RESOLUTIONS PASSED | RNS |
